Marion Gruber is the Signatory Authority listed on the Emergency Use Authorization. Marion Gruber, director of the FDA’s Office of Vaccines Research & Review, and deputy director Phil Krause will exit the agency in October and November, respectively, according to a letter shared with CNBC by FDA spokeswoman Stephanie Caccomo. A former senior FDA leader…
Chronological Sequence of Events